Showing codes J7202 (Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.) — J7314 (Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg)

J7202 - Factor ix idelvion inj
Long description: Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7203 - Factor ix recomb gly rebinyn
Long description: Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7204 - Inj recombin esperoct per iu
Long description: Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
Code added date: 20200701.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7205 - Factor viii fc fusion recomb
Long description: Injection, factor viii fc fusion protein (recombinant), per iu
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7207 - Factor viii pegylated recomb
Long description: Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7208 - Inj. jivi 1 iu
Long description: Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
Code added date: 20190701.
Code effective date: 20190701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7209 - Factor viii nuwiq recomb 1iu
Long description: Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7210 - Inj, afstyla, 1 i.u.
Long description: Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7211 - Inj, kovaltry, 1 i.u.
Long description: Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7212 - Factor viia recomb sevenfact
Long description: Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
Code added date: 20210101.
Code effective date: 20210101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7213 - Inj, ixinity, 1 i.u.
Long description: Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7214 - Altuviiio per factor viii iu
Long description: Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.
Code added date: 20231001.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7294 - Seg acet and eth estr yearly
Long description: Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7295 - Eth estr and eton monthly
Long description: Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7296 - Kyleena, 19.5 mg
Long description: Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7297 - Liletta, 52 mg
Long description: Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
Code added date: 20160101.
Code effective date: 20170101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7298 - Mirena, 52 mg
Long description: Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
Code added date: 20160101.
Code effective date: 20170101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7300 - Intraut copper contraceptive
Long description: Intrauterine copper contraceptive
Code added date: 19860101.
Code effective date: 19960101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7301 - Skyla, 13.5 mg
Long description: Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
Code added date: 20140101.
Code effective date: 20170101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7302 - Levonorgestrel iu 52 mg
Long description: Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
Code added date: 20020101.
Code effective date: 20160101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7303 - Contraceptive vaginal ring
Long description: Contraceptive supply, hormone containing vaginal ring, each
Code added date: 20040101.
Code effective date: 20211001.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7304 - Contraceptive hormone patch
Long description: Contraceptive supply, hormone containing patch, each
Code added date: 20050101.
Code effective date: 20050101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: S (A code denoting Medicare coverage status).
HTML    PDF

J7306 - Levonorgestrel implant sys
Long description: Levonorgestrel (contraceptive) implant system, including implants and supplies
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

J7307 - Etonogestrel implant system
Long description: Etonogestrel (contraceptive) implant system, including implant and supplies
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

J7308 - Aminolevulinic acid hcl top
Long description: Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
Code added date: 20020101.
Code effective date: 20040101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7309 - Methyl aminolevulinate, top
Long description: Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
Code added date: 20110101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7310 - Ganciclovir long act implant
Long description: Ganciclovir, 4.5 mg, long-acting implant
Code added date: 19970101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7311 - Inj., retisert, 0.01 mg
Long description: Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
Code added date: 20070101.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7312 - Dexamethasone intra implant
Long description: Injection, dexamethasone, intravitreal implant, 0.1 mg
Code added date: 20110101.
Code effective date: 20110101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7313 - Inj., iluvien, 0.01 mg
Long description: Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
Code added date: 20160101.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7314 - Inj., yutiq, 0.01 mg
Long description: Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF